The organization hopes to offer a drug in the next four years that, studies show, can save brain tissue in people who have suffered an ischemic stroke and receive the drug intravenously for 48 hours immediately after surgeons remove the stroke-causing clot from the patient’s brain.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.